PHOSPHATIDYLSERINE REDUCES IMMUNE RESPONSE AGAINST HUMAN RECOMBINANT FVIII IN HEMOPHILIA A MICE BY REGULATION OF DENDRITIC CELL FUNCTION

A major clinical complication in the treatment of Hemophilia A using exogenously administered recombinant Factor VIII (FVIII) is the development of neutralizing antibodies. It has been shown previously that FVIII complexed with phosphatidylserine (PS) reduces the development of total and neutralizin...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Gaitonde, Puneet, Peng, Aaron, Straubinger, Robert M., Bankert, Richard B., Balu-Iyer, Sathy V.
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3059555/
https://ncbi.nlm.nih.gov/pubmed/21094627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clim.2010.10.006
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki